|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61P 35/00 | |||
| G01N 33/68 |
| (11) | Patento numeris | 3023788 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15198284.0 |
| Europos patento paraiškos padavimo data | 2011-05-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 334866 P | 2010-05-14 | US |
| (72) |
HACOHEN, Nir, US
WU, Catherine, US
|
| (73) |
The General Hospital Corporation,
55 Fruit Street, Boston, MA 02114,
US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US |
| (54) | COMPOSITIONS OF TUMOR SPECIFIC NEOANTIGENS FOR USE IN TREATING TUMOURS |
| COMPOSITIONS OF TUMOR SPECIFIC NEOANTIGENS FOR USE IN TREATING TUMOURS |